Patient recruitment agency

AutoCruitment

Direct-to-patient digital recruitment with a proprietary pre-screener.

What they actually do

Runs paid digital campaigns (largely social and search) into a branded pre-screening funnel, then routes qualified referrals to sites. The pitch is speed: campaigns can be live within days of protocol sign-off, and sponsors see referral volume quickly.

How they price

Typically a campaign fee plus media spend, sometimes with per-referral or performance components. Publicly listed pricing is not available; ask for cost per randomized patient, not cost per referral.

Whatever the structure, convert it to cost per randomized patient before you compare proposals. Cost per referral is the number vendors prefer to quote and the number that tells you least.

Where they are strong

  • Fast campaign launch and high top-of-funnel referral volume
  • Well-developed pre-screening technology and site-facing portal
  • Markets dermatology and other visible-symptom indications heavily in its published case studies

What to watch for

  • Referral volume is not enrollment. Ask for the referral-to-randomization ratio on studies like yours.
  • Ask how many referrals per week your coordinators will be expected to work, and what happens if they cannot keep up.
  • Its public materials centre on paid digital channels. Ask what share of referrals came from non-paid sources, and how performance held up when media costs rose.

Is AutoCruitment worth it?

Worth it when: Sponsors with a broad, self-identifying patient population and sites that have coordinator bandwidth to work a large referral queue.

Not worth it when: Ultra-rare indications where the addressable population cannot be reached economically through paid social.

AutoCruitment alternatives

Head to head

Before you sign anything

Ask for the referral-to-randomization ratio on three studies resembling yours, in the same indication and the same countries. If a vendor will not give it, that is the answer. If your enrollment forecast itself is the shaky part, our sister publication Rock Enroll covers forecasting and rescue in depth.

This profile is compiled from public sources: the company's own website and case studies, trial registries, and trade press. Statements about performance are framed as questions to put to the vendor rather than claims about it. AutoCruitment did not review or approve this page. Corrections are welcome and get made.